Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dosing Study of Microbiota Transplant Therapy for Children With Autism Spectrum Disorder (ASD) Who Have Gastrointestinal Disorders

NCT06503978 is registered in ClinicalTrials.gov with Gut-Brain-Axis Therapeutics Inc. as lead sponsor.

NCT NCT06503978
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06503978 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dosing Study of Microbiota Transplant Therapy for Children With Autism Spectrum Disorder (ASD) Who Have Gastrointestinal Disorders
Lead sponsor
Gut-Brain-Axis Therapeutics Inc.
Phase
Phase 2
Overall status
Active, not recruiting
Start date
August 20, 2024
Completion date
August 17, 2026
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autism spectrum disorder, constipation, diarrhea, gastro-intestinal disorder